The Prescription Drug Affordability Board (PDAB) posted its agenda materials for the May 20 meeting. Check the PDAB website for updates prior to the meeting. Register in advance.
For more information, contact NACDS’ Sandra Guckian at 703-774-4801.
The Department of Insurance (PID) announced the launch of a new online portal specifically for pharmacies to submit complaints related to the enforcement of Act 77, the 2024 PBM commercial market reform law. The new portal is intended to create a single, streamlined submission form that collects all required information and allows pharmacies to file complaints related to clawbacks, steering, rebates, reimbursement and specialty drug designations. NACDS encourages members to test the portal and share your feedback with Jill McCormack.
For more information, contact NACDS’ Jill McCormack at 717-592-8977.
Federal law requires all providers who order, refer or prescribe (ORP) services or items for Medicaid members to be enrolled in respective state Medicaid programs. Currently, pharmacists are notified at point of sale if prescriptions were written by a non-enrolled Department of Health and Human Services (SCDHHS) provider with the statement “prescriber enrollment is required in SC’s Medicaid program.” Pharmacists that dispense vaccines and naloxone through South Carolina protocols without a prescription are required to be enrolled in South Carolina’s Healthy Connections Medicaid program. Please refer to information provided by the South Carolina Pharmacy Association.
For more information, contact NACDS’ Leigh Knotts at 803-243-7207.
The Department of Health Care Services posted the following on the Medi-Cal Rx Web Portal:
For more information, contact NACDS’ Sandra Guckian at 703-774-4801.
HB26-1336, legislation that expands access to pharmacy healthcare services and authorizes payment for these services for both Medicaid and commercial patients, passed the Senate Health and Human Services Committee and awaits a final vote by the Senate. The bill enables children 12 years of age and under to receive test-and-treat services directly from pharmacies. It also allows pharmacy technicians, under pharmacist supervision, to perform final product verification and other technical, non-discretionary tasks.
Also in Colorado, the Board of Pharmacy released Volume 18, Winter 2026 and Volume 19, Spring 2026 of its newsletter providing updates on regulatory developments and Board activities.
For more information, contact NACDS’ Mary Staples at 817-442-1155.
HB 5375 was passed by the Legislature this week and is expected to be signed into law by Gov. Ned Lamont (D). The legislation, which has been an NACDS priority for the 2026 session, prohibits an insurance carrier from denying pharmacy reimbursement based solely on a provider’s license type for any “covered clinical service” that falls within a pharmacist’s scope and is otherwise eligible for reimbursement when performed by a physician, physician assistant or advanced practice registered nurse.
For more information, please contact NACDS’ Mike Sargent at 207-272-6435.
The Department of Health announced a new licensure experience for health care practitioners on April 29.
For more information, contact NACDS’ Leigh Knotts at 803-243-7207.
HB 2068, an omnibus bill incorporating key pharmacy-supported provisions from HB 2676, HB 2740, SB 322 and SB 431, passed both legislative chambers and was signed into law by Governor Laura Kelly (D). The bill expands pharmacists’ prescribing authority under standard of care regulations and permits remote pharmacy services by pharmacy technicians.
For more information, contact NACDS’ Mary Staples at 817-442-1155.
The Prescription Drug Advisory Board is soliciting comments on proposed revisions to COMAR 14.01.04 (cost study process). Written comments are due by 12:00 noon on May 8 to pdab.regs@maryland.gov. For more information, visit the Board’s website.
For more information, contact NACDS’ Jill McCormack at 717-592-8977.
